SOUTHWESTERN DRUG TOP MANAGEMENT WILL REMAIN INTACT
SOUTHWESTERN DRUG TOP MANAGEMENT WILL REMAIN INTACT following the May 7-announced acquisition of the whslr. by DMH Corp. from Gulf Broadcast Company. President and Chief exec Gene Vykukal "will continue in his present capacity," the press release stated. Vykukal "anticipates no changes in the officers or other management of the company." DHM is a privately-held, Dallas-based investment company managed by founder, sole owner and chief exec David H. Monnich. The firm has "extensive and diverse" holdings throughout Texas and Louisiana, according to Southwestern. The whslr. is DHM's first venture in the health care field. Headquartered in Dallas, Southwestern services 3,000 pharmacies, hospitals and clinics in Texas, Louisiana, Oklahoma, New Mexico and Arkansas. The whslr. has distribution centers in the Dallas-Fort Worth area, Houston, San Antonio and Harlingen, Texas, Southwestern was acquired by Gulf in 1979.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth